Rapid clearance of extensive juvenile pityriasis rubra pilaris with ixekizumab.
Pediatr Dermatol
; 2024 Jul 24.
Article
en En
| MEDLINE
| ID: mdl-39044645
ABSTRACT
Juvenile pityriasis rubra pilaris is a rare inflammatory skin disorder currently without any FDA-approved treatments, and lesions can be refractory to conventional treatment with topical corticosteroids, methotrexate, and oral retinoids. We herein present a case of a 6-year-old boy who attained clearance of extensive juvenile pityriasis rubra pilaris within 2 weeks of starting ixekizumab therapy. Therapeutic effect has been durable at 6 months, and patient continues on therapy without adverse effects. Our case highlights a new, rapidly effective treatment option for pediatric patients with this rare condition.
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Pediatr Dermatol
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos